Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma Ruchika Sharma5 Jun 2022 3:00 PM ISTMCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.
Patent infringement: JnJ, Momenta Pharma file case against Natco, Mylan Pharma Ruchika Sharma26 May 2022 3:54 PM ISTHyderabad: Johnson & Johnson's and Momenta Pharmaceuticals have filed a lawsuit against Natco Pharma and its marketing partner Mylan...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella Ruchika Sharma21 May 2022 10:00 AM ISTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
Blood clot risk - USFDA limits use of JnJ COVID vaccine Ruchika Sharma6 May 2022 12:54 PM ISTThe vaccine maker said it has updated the U.S. COVID-19 vaccine fact sheet to warn about the risk of thrombosis with thrombocytopenia syndrome (TTS),...
JnJ suspends sales forecast for COVID vaccine Ruchika Sharma20 April 2022 12:09 PM ISTJnJ said it now expects full-year adjusted profit forecast to be between $10.15 and $10.35 per share, lower than the prior forecast of $ 10.40 to $...
J&J unit proposes independent exam if it remains in bankruptcy Ruchika Sharma20 Feb 2022 9:00 AM ISTNew Delhi: A Johnson & Johnson subsidiary proposed on Friday that it would submit to an independent examination of the corporate...
Medical devices, prescription drugs boost JnJ earning in Q4 Ruchika Sharma27 Jan 2022 9:00 AM ISTWashington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...
Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
USFDA warns against rare bleeding risk of JnJ COVID vaccine Ruchika Sharma12 Jan 2022 4:15 PM ISTNew Delhi: The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare...
JnJ Single shot vaccine protects against breakthrough COVID-19 for up to 6 months: Study Roshni Dhar12 Jan 2022 11:47 AM ISTJohnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and...
Johnson and Johnson, Costco settle lawsuits over recalled sunscreen Ruchika Sharma2 Nov 2021 4:37 PM ISTNew Delhi: Johnson & Johnson and Costco Wholesale Corp have reached a tentative agreement to settle lawsuits over the presence of a...
JnJ spends Rs 5989 crore to settle most Risperdal lawsuits Ruchika Sharma1 Nov 2021 3:38 PM ISTNew Delhi: Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal...
